You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on CypComp Database.
Record Information
Version1.0
Creation Date2019-07-14 16:16:10 UTC
Last Updated2019-10-01 21:37:11 UTC
CypComp IDCC00044
Compound Information
NameBDB
Structure ImageVhmrxgaiddcgdu vifpvbqesa n
InChIKeyVHMRXGAIDDCGDU-VIFPVBQESA-N
PubChem ID54579998
CypCompound Information
SetCypReact Training Set
Reactant Statuses
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
Non-ReactantNon-ReactantNon-ReactantNon-ReactantNon-ReactantReactantReactantNon-ReactantReactant
References
  1. Meyer MR, Peters FT, Maurer HH: Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers. Toxicol Lett. 2009 Oct 8;190(1):54-60. doi: 10.1016/j.toxlet.2009.06.866. Epub 2009 Jul 2. [PubMed:19576971 ]
  2. Maurer HH, Bickeboeller-Friedrich J, Kraemer T, Peters FT: Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy'). Toxicol Lett. 2000 Mar 15;112-113:133-42. [PubMed:10720722 ]
Download FileCC00044.sdf